Early Stage Investigator Spotlight: Girish Hiremath Explores the Epidemiology of Eosinophilic Gastrointestinal Diseases Dakota Campbell Fri, 03/04/2022 - 10:33
Headshot of Girish Hiremath, MD, MPH

Girish Hiremath, MD, MPH, is a pediatric gastroenterologist leading the pediatric Eosinophilic Gastrointestinal Disorders clinic at Vanderbilt University. He is also a member of the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Dr. Hiremath’s research focuses on the epidemiology, pathogenesis, diagnosis, and management of eosinophilic gastrointestinal diseases (EGIDs). Here, he shares his start in rare disease research, exciting discoveries, and future goals. 

CEGIR Researchers Report on the FDA Workshop: Challenges, Progress, Questions in Eosinophilic Gastrointestinal Disorders jaquelyn.freie… Thu, 01/13/2022 - 08:24
Marc Rothenberg, MD, PhD, with a future researcher of eosinophilic disease
Marc Rothenberg, MD, PhD, with a future researcher of eosinophilic disease

The U.S. Food and Drug Administration (FDA) hosted a workshop on July 21, 2021 to discuss the disease characteristics, natural history, and endpoints to assess treatment benefit in patients with eosinophilic gastrointestinal disorders (EGID) beyond eosinophilic esophagitis (EoE).